Medical Technology

@xconomy.com 3 years ago

Codiak Bio’s IPO Brings In $82M as Exosome Clinical Trials Begin

@xconomy.com 4 years ago

With $45M, Mammoth Bio Expects Big Things From Tiny CRISPR Cas14

@xconomy.com 4 years ago

Liquid Biopsy Firm Lucence Plans Bay Area Buildout With $20M in Tow

@xconomy.com 4 years ago

Flagship’s Omega Aims to Take Epigenetic Drugs a Step Further

@xconomy.com 4 years ago

MedCo Touts New Data for Long-Lasting Heart Drug as Reckoning Looms

@xconomy.com 5 years ago

Bio Roundup: Trump’s Scalps, Policy Pressure, NASH Crash & More

@xconomy.com 5 years ago

Bio Roundup: Trump’s Scalps, Policy Pressure, NASH Crash & More

@xconomy.com 5 years ago

CVS Health Expands Delivery, as Pharmacies Try to Keep Amazon at Bay

@xconomy.com 5 years ago

Teladoc Buys Advance Medical for $352M to Expand Telehealth Services